Concepedia

Author

Ikuto Tsukiyama

Aichi Medical UniversityORCID

Also Known As

Ikuto Tsukiyama

31

Publications

205

Citations

9

H-Index

38

Concepts

All Affiliations

Aichi Medical UniversityMeijo UniversityOhu UniversityTeikyo Heisei UniversityNagoya University
IT

About

Ikuto Tsukiyama is an author at Aichi Medical University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

66

2

Health Sciences

3

3

55

3

Biochemistry

2

2

26

4

Health Policy

1

1

15

5

Hepatology

1

1

15

Ikuto Tsukiyama

×

9

Publications

169

Citations

9

H-Index

YearCitations

Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin.

Yoshihiro Yamamoto, Kazushi Watanabe, Ikuto Tsukiyama,

PubMed

2015

41

Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomes.

Maki Arakawa-Todo, Takahiko Yoshizawa, Kenji Zennami,

PubMed

2013

25

Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.

Yoshihiro Yamamoto, Kazushi Watanabe, Ikuto Tsukiyama,

PubMed

2016

19

Multivariate analysis of risk factors for cisplatin‐induced nephrotoxicity in gynecological cancer

Yoshihiro Yamamoto, Kazushi Watanabe, Hiroshi Matsushita,

Journal of obstetrics and gynaecology research

2017

16

Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.

K Hotta, Jun Ueyama, Yasuaki Tatsumi,

PubMed

2015

15

A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

Ikuto Tsukiyama, Masayuki Ejiri, Yoshihiro Yamamoto,

Journal of Gastrointestinal Cancer

2016

15

Cost‐effectiveness of aprepitant in Japanese patients treated with cisplatin‐containing highly emetogenic chemotherapy

Ikuto Tsukiyama, Shiori Hasegawa, Yoshiaki Ikeda,

Cancer Science

2018

15

Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia

Ikuto Tsukiyama, Takashi Iwata, Tomoko Takeuchi,

Supportive Care in Cancer

2023

12

Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.

Yukio Toyama, Jun Ueyama, Hiroshi Nomura,

PubMed

2014

11

Page 1